Nidogen-2 (NID2) is a Key Factor in Collagen Causing Poor Response to Immunotherapy in Melanoma
Sign Up to like & getrecommendations! Published in 2023 at "Pharmacogenomics and Personalized Medicine"
DOI: 10.2147/pgpm.s399886
Abstract: Background The incidence of cutaneous melanoma continues to rise rapidly and has an extremely poor prognosis. Immunotherapy strategies are the most effective approach for patients who have developed metastases, but not all cases have been… read more here.
Keywords: melanoma; immunotherapy; collagen; nidogen nid2 ... See more keywords